FY24 Funding, EPA
FY24 Funding, USAID
FY24 Funding, VA
FY24 Funding, DoD
FY24 Funding, HHS
Tobacco Policy
Medical Research
Public Health Programs
Duration: January 1, 2008
to
present
General Issues: Budget/Appropriations , Health Issues
Spending: about $620,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: U.S. Senate, House of Representatives, Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Natl Institutes of Health (NIH)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2024
In Q2, Health and Medicine Counsel, LLC lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on July 2.
Original Filing: 301581150.xml
Lobbying Issues
FY24 Funding, EPA
FY24 Funding, USAID
FY24 Funding, VA
FY24 Funding, DoD
FY24 Funding, HHS
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Tobacco Policy
Medical Research
Public Health Programs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2024
Health and Medicine Counsel, LLC amended a lobbying report for representation of AMERICAN LUNG ASSOCIATION in Q12024 on April 16.
Original Filing: 301550926.xml
Lobbying Issues
FY24 Funding, EPA
FY24 Funding, USAID
FY24 Funding, VA
FY24 Funding, DoD
FY24 Funding, HHS
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Tobacco Policy
Medical Research
Public Health Programs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2024
Health and Medicine Counsel, LLC amended a lobbying report for representation of AMERICAN LUNG ASSOCIATION in Q12024 on April 4.
Original Filing: 301546484.xml
Lobbying Issues
FY24 Funding, EPA
FY24 Funding, USAID
FY24 Funding, VA
FY24 Funding, DoD
FY24 Funding, HHS
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Tobacco Policy
Medical Research
Public Health Programs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2024
In Q1, Health and Medicine Counsel, LLC lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on April 1.
Original Filing: 301545765.xml
Lobbying Issues
FY24 Funding, EPA
FY24 Funding, USAID
FY24 Funding, VA
FY24 Funding, DoD
FY24 Funding, HHS
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Tobacco Policy
Medical Research
Public Health Programs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2023
Health and Medicine Counsel, LLC amended a lobbying report for representation of AMERICAN LUNG ASSOCIATION in Q42023 on April 17.
Original Filing: 301551653.xml
Lobbying Issues
FY24 Funding, EPA
FY24 Funding, USAID
FY24 Funding, VA
FY24 Funding, DoD
FY24 Funding, HHS
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Tobacco Policy
Medical Research
Public Health Programs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2023
In Q4, Health and Medicine Counsel, LLC lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Jan. 3.
Original Filing: 301521490.xml
Lobbying Issues
FY24 Funding, EPA
FY24 Funding, USAID
FY24 Funding, VA
FY24 Funding, DoD
FY24 Funding, HHS
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Tobacco Policy
Medical Research
Public Health Programs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2023
Health and Medicine Counsel, LLC amended a lobbying report for representation of AMERICAN LUNG ASSOCIATION in Q32023 on April 17.
Original Filing: 301551901.xml
Lobbying Issues
FY24 Funding, EPA
FY24 Funding, USAID
FY24 Funding, VA
FY24 Funding, DoD
FY24 Funding, HHS
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Tobacco Policy
Medical Research
Public Health Programs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2023
Health and Medicine Counsel, LLC amended a lobbying report for representation of AMERICAN LUNG ASSOCIATION in Q32023 on Oct. 16, 2023.
Original Filing: 301501050.xml
Lobbying Issues
FY24 Funding, EPA
FY24 Funding, USAID
FY24 Funding, VA
FY24 Funding, DoD
FY24 Funding, HHS
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Tobacco Policy
Medical Research
Public Health Programs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2023
In Q3, Health and Medicine Counsel, LLC lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Oct. 4, 2023.
Original Filing: 301497595.xml
Lobbying Issues
FY24 Funding, EPA
FY24 Funding, USAID
FY24 Funding, VA
FY24 Funding, DoD
FY24 Funding, HHS
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Tobacco Policy
Medical Research
Public Health Programs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2023
In Q2, Health and Medicine Counsel, LLC lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on July 6, 2023.
Original Filing: 301473343.xml
Lobbying Issues
FY24 Funding, EPA
FY24 Funding, USAID
FY24 Funding, VA
FY24 Funding, DoD
FY24 Funding, HHS
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Tobacco Policy
Medical Research
Public Health Programs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2023
In Q1, Health and Medicine Counsel, LLC lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on April 6, 2023.
Original Filing: 301449273.xml
Lobbying Issues
FY24 Funding, EPA
FY24 Funding, USAID
FY24 Funding, VA
FY24 Funding, DoD
FY24 Funding, HHS
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Tobacco Policy
Medical Research
Public Health Programs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2022
In Q4, Health and Medicine Counsel, LLC lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Jan. 1, 2023.
Original Filing: 301424402.xml
Lobbying Issues
FY22 Defense
FY22 Int/Env
FY22 LHHS
FY22 MilCon-VA
FY22 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
E-cig & menthol policy
Wild Fire Spending
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2022
In Q3, Health and Medicine Counsel, LLC lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Oct. 5, 2022.
Original Filing: 301401400.xml
Lobbying Issues
FY22 Defense
FY22 Int/Env
FY22 LHHS
FY22 MilCon-VA
FY22 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
E-cig & menthol policy
Wild Fire Spending
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2022
In Q2, Health and Medicine Counsel, LLC lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on July 12, 2022.
Original Filing: 301378946.xml
Lobbying Issues
FY22 Defense
FY22 Int/Env
FY22 LHHS
FY22 MilCon-VA
FY22 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
E-cig & menthol policy
Wild Fire Spending
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2022
Health and Medicine Counsel, LLC filed a lobbying registration on April 14, 2022 to represent AMERICAN LUNG ASSOCIATION, effective April 14, 2022.
Original Filing: 301355937.xml
Issue(s) they said they’d lobby about: BUD:
FY 22 Defense
FY22 Int/Env
FY22 LHHS
FY22 MilCon-VA
FY22 Ag/FDA
HCR:
Center for Tobacco Products/Tobacco User fees
Lung Health issues (ASTHMA, TB, COPD)
CDC Chronic Disease Education and Awareness Program
E-cig & menthol policy
Wild Fire Spending .
1st Quarter, 2022
In Q1, Health and Medicine Counsel, LLC lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on April 14, 2022.
Original Filing: 301356070.xml
Lobbying Issues
FY22 Defense
FY22 Int/Env
FY22 LHHS
FY22 MilCon-VA
FY22 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
E-cig & menthol policy
Wild Fire Spending
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2022
Health and Medicine Counsel, LLC amended a lobbying report for representation of AMERICAN LUNG ASSOCIATION in Q12022 on April 14, 2022.
Original Filing: 301356090.xml
Lobbying Issues
FY22 Defense
FY22 Int/Env
FY22 LHHS
FY22 MilCon-VA
FY22 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
E-cig & menthol policy
Wild Fire Spending
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2021
In Q4, Health and Medicine Counsel, LLC lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Jan. 14, 2022.
Original Filing: 301322415.xml
Lobbying Issues
FY22 Defense
FY22 Int/Env
FY22 LHHS
FY22 MilCon-VA
FY22 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
E-cig & menthol policy
Wild Fire Spending
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2021
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Oct. 4, 2021.
Original Filing: 301296425.xml
Lobbying Issues
FY22 Defense
FY22 Int/Env
FY22 LHHS
FY22 MilCon-VA
FY22 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
E-cig & menthol policy
Wild Fire Spending
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2021
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on July 7, 2021.
Original Filing: 301273871.xml
Lobbying Issues
FY22 Defense
FY22 Int/Env
FY22 LHHS
FY22 MilCon-VA
FY22 Ag/FDA
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
COVID-19 Relief Packages
Wild Fire Spending
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2021
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on April 7, 2021.
Original Filing: 301251096.xml
Lobbying Issues
FY22 Defense
FY22 Int/Env
FY22 LHHS
FY22 MilCon-VA
FY22 Ag/FDA
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
COVID-19 Relief Packages
Wild Fire Spending
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2020
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Jan. 13, 2021.
Original Filing: 301230340.xml
Lobbying Issues
FY21 Defense
FY21 Int/Env
FY21 LHHS
FY21 MilCon-VA
FY21 Ag/FDA
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.294 / H.R. 564: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
COVID-19 Relief Packages
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2020
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Oct. 8, 2020.
Original Filing: 301208070.xml
Lobbying Issues
FY21 Defense
FY21 Int/Env
FY21 LHHS
FY21 MilCon-VA
FY21 Ag/FDA
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.294 / H.R. 564: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
COVID-19 Relief Packages
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2020
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on July 7, 2020.
Original Filing: 301185600.xml
Lobbying Issues
FY21 Defense
FY21 Int/Env
FY21 LHHS
FY21 MilCon-VA
FY21 Ag/FDA
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.294 / H.R. 564: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
COVID-19 Relief Packages
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2020
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on April 9, 2020.
Original Filing: 301154902.xml
Lobbying Issues
FY20 Defense
FY20 Int/Env
FY20 LHHS
FY20 MilCon-VA
FY20 Ag/FDA
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.294 / H.R. 564: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
COVID-19 Relief Packages
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2019
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Jan. 15, 2020.
Original Filing: 301105779.xml
Lobbying Issues
FY20 Defense
FY20 Int/Env
FY20 LHHS
FY20 MilCon-VA
FY20 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.294 / H.R. 564: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2019
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Oct. 4, 2019.
Original Filing: 301063289.xml
Lobbying Issues
FY19 Defense
FY19 Int/Env
FY19 LHHS
FY19 MilCon-VA
FY19 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.294 / H.R. 564: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2019
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on July 9, 2019.
Original Filing: 301043749.xml
Lobbying Issues
FY19 Defense
FY19 Int/Env
FY19 LHHS
FY19 MilCon-VA
FY19 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.294 / H.R. 564: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2019
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on April 11, 2019.
Original Filing: 301024172.xml
Lobbying Issues
FY19 Defense
FY19 Int/Env
FY19 LHHS
FY19 MilCon-VA
FY19 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.294 / H.R. 564: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2018
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Jan. 7, 2019.
Original Filing: 301002447.xml
Lobbying Issues
FY19 Defense
FY19 Int/Env
FY19 LHHS
FY19 MilCon-VA
FY19 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.294 / H.R. 564: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2018
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Oct. 10, 2018.
Original Filing: 300984008.xml
Lobbying Issues
FY19 Defense
FY19 Int/Env
FY19 LHHS
FY19 MilCon-VA
FY19 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.294 / H.R. 564: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2018
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on July 11, 2018.
Original Filing: 300963584.xml
Lobbying Issues
FY19 Defense
FY19 Int/Env
FY19 LHHS
FY19 MilCon-VA
FY19 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.294 / H.R. 564: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2018
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on April 11, 2018.
Original Filing: 300943678.xml
Lobbying Issues
FY18 Defense
FY18 Int/Env
FY18 LHHS
FY18 MilCon-VA
FY18 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.294 / H.R. 564: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2017
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Jan. 10, 2018.
Original Filing: 300922335.xml
Lobbying Issues
FY17 Defense
FY17 Int/Env
FY17 LHHS
FY17 MilCon-VA
FY17 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.294 / H.R. 564: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2017
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Oct. 6, 2017.
Original Filing: 300901697.xml
Lobbying Issues
FY17 Defense
FY17 Int/Env
FY17 LHHS
FY17 MilCon-VA
FY17 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.294 / H.R. 564: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2017
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on July 12, 2017.
Original Filing: 300883595.xml
Lobbying Issues
FY17 Defense
FY17 Int/Env
FY17 LHHS
FY17 MilCon-VA
FY17 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.294 / H.R. 564: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2017
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on April 11, 2017.
Original Filing: 300863925.xml
Lobbying Issues
FY17 Defense
FY17 Int/Env
FY17 LHHS
FY17 MilCon-VA
FY17 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.441 / H.R. 662: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2016
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Jan. 6, 2017.
Original Filing: 300843959.xml
Lobbying Issues
FY17 Defense
FY17 Int/Env
FY17 LHHS
FY17 MilCon-VA
FY17 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.441 / H.R. 662: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2016
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Oct. 14, 2016.
Original Filing: 300827925.xml
Lobbying Issues
FY17 Defense
FY17 Int/Env
FY17 LHHS
FY17 MilCon-VA
FY17 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.441 / H.R. 662: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2016
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on July 13, 2016.
Original Filing: 300808829.xml
Lobbying Issues
FY16 Defense
FY16 Int/Env
FY16 LHHS
FY16 MilCon-VA
FY16 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.441 / H.R. 662: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2016
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on April 7, 2016.
Original Filing: 300788810.xml
Lobbying Issues
FY16 Defense
FY16 Int/Env
FY16 LHHS
FY16 MilCon-VA
FY16 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.441 / H.R. 662: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2015
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Jan. 14, 2016.
Original Filing: 300771602.xml
Lobbying Issues
FY16 Defense
FY16 Int/Env
FY16 LHHS
FY16 MilCon-VA
FY16 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.441 / H.R. 662: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2015
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Oct. 14, 2015.
Original Filing: 300752765.xml
Lobbying Issues
FY16 Defense
FY16 Int/Env
FY16 LHHS
FY16 MilCon-VA
FY16 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.441 / H.R. 662: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2015
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on July 10, 2015.
Original Filing: 300733052.xml
Lobbying Issues
FY16 Defense
FY16 Int/Env
FY16 LHHS
FY16 MilCon-VA
FY16 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.441 / H.R. 662: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2015
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on April 13, 2015.
Original Filing: 300714437.xml
Lobbying Issues
FY16 Defense
FY16 Int/Env
FY16 LHHS
FY16 MilCon-VA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S.441 / H.R. 662: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2014
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Jan. 16, 2015.
Original Filing: 300697562.xml
Lobbying Issues
FY15 Defense
FY15 Int/Env
FY15 LHHS
FY15 MilCon-VA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S. 772 / H.R. 792: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2014
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Oct. 17, 2014.
Original Filing: 300679096.xml
Lobbying Issues
FY15 Defense
FY15 Int/Env
FY15 LHHS
FY15 MilCon-VA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S. 772 / H.R. 792: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2014
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on July 8, 2014.
Original Filing: 300654003.xml
Lobbying Issues
FY15 Defense
FY15 Int/Env
FY15 LHHS
FY15 MilCon-VA
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S. 772 / H.R. 792: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2014
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on April 16, 2014.
Original Filing: 300637695.xml
Lobbying Issues
FY14 & FY15 Defense
FY14 & FY15 Int/Env
FY14 & FY15 LHHS
FY14 & FY15 MilCon-VA
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Center for Tobacco Products/Tobacco User fees
Lung health issues (e.g. asthma, TB & COPD)
S. 772 / H.R. 792: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2013
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Jan. 10, 2014.
Original Filing: 300614484.xml
Lobbying Issues
FY 14 Defense
FY 14 Int/Env
FY14 LHHS
FY 14 MilCon-VA
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
H.R. 2112: Lung Cancer Mortality Reduction Act
H.R. 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic
obstructive pulmonary disease
Center for Tobacco Products/Tobacco User feesLung health issues (e.g. asthma, TB & COPD)
H.R. 1639 & S. 1461: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act of 2011
H.R. 6190: Asthma Inhalers Relief Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2013
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Oct. 9, 2013.
Original Filing: 300591546.xml
Lobbying Issues
FY 14 Defense
FY 14 Int/Env
FY14 LHHS
FY 14 MilCon-VA
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
H.R. 2112: Lung Cancer Mortality Reduction Act
H.R. 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic
obstructive pulmonary disease
Center for Tobacco Products/Tobacco User feesLung health issues (e.g. asthma, TB & COPD)
H.R. 1639 & S. 1461: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act of 2011
H.R. 6190: Asthma Inhalers Relief Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2013
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on July 9, 2013.
Original Filing: 300569844.xml
Lobbying Issues
FY14 Defense
FY14 Int/Env
FY14 L-HHS
FY14 MilCon-VAFY13 Ag/FDA
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
H.R. 2112: Lung Cancer Mortality Reduction Act
H.R. 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic obstructive pulmonary disease
Center for Tobacco Products/Tobacco User feesLung health issues (e.g. asthma, TB & COPD)
H.R. 1639 & S. 1461: Traditional Cigar Manufacturing and Small Business Jobs Prevention Act of 2011
H.R. 6190: Asthma Inhalers Relief Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2013
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on April 18, 2013.
Original Filing: 300552904.xml
Lobbying Issues
FY13 & 14 Defense
FY13 & 14 Int/Env
FY13 & 14 L-HHS
FY13 & 14 MilCon-VAFY13 Ag/FDA
H.R. 8: American Taxpayer Relief Act of 2012
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
H.R. 2112: Lung Cancer Mortality Reduction Act
H.R. 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic
obstructive pulmonary disease
Center for Tobacco Products/Tobacco User feesLung health issues (e.g., asthma, TB & COPD)
S. 2057: A bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practitioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilition programs.
H.R. 1639 & S. 1461: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2011.
H.R. 6190: Asthma Inhalers Relief Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2012
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Jan. 11, 2013.
Original Filing: 300527451.xml
Lobbying Issues
FY13 State For. Ops.
FY13 Defense
FY13 Int/Env.
FY13 L-HHSFY13 MilCon-VA
FY13 Ag/FDA
FY13 Interior
HR 8: American Taxpayer Relief Act of 2012
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
H.R. 2112: Lung Cancer Mortality Reduction Act
H.R. 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic obstructive pulmonary disease
Center for Tobacco Products/Tobacco User feesLung health issues (e.g., asthma, TB & COPD)
S. 2057: A bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practioners, and clinical nurse
specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilition programs.
H.R. 1639 & S. 1461: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2011.
H.R. 6190: Asthma Inhalers Relief Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2012
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Oct. 17, 2012.
Original Filing: 300508701.xml
Lobbying Issues
FY13 State For. Ops.
FY13 Defense
FY13 Int/Env
FY13 L-HHSFY13 MilCon-VA
FY13 Ag/FDA
FY13 Interior
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
H.R. 2112: Lung Cancer Mortality Reduction Act
H.R. 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic obstructive pulmonary disease
Center for Tobacco Products/Tobacco User feesLung health issues (e.g., asthma, TB & COPD)
S. 2057: A bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs
H.R. 1639 & S. 1461: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2011
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2012
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on July 13, 2012.
Original Filing: 300483381.xml
Lobbying Issues
FY13 State/For. Ops.
FY13 Defense
FY13 Int/Env
FY13 L-HHSFY13 MilCon/VA
FY13 Ag/FDA
FY13 Interior
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
H.R. 2112: Lung Cancer Mortality Reduction Act
H.R. 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic obstructive pulmonary disease
Center for Tobacco Products/Tobacco User feesLung health issues (e.g., asthma, TB & COPD)
S. 2057: A bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs.
H.R. 1639 & S. 1461: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2011.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2012
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on April 9, 2012.
Original Filing: 300458343.xml
Lobbying Issues
FY13 State/For. Ops.
FY13 Defense
FY13 Int/Env.
FY13 L-HHSFY13 MilCon/VA
FY13 Ag/FDA
FY13 Interior
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
H.R. 2112: Lung Cancer Mortality Reduction Act
H.R. 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic
obstructive pulmonary disease
Center for Tobacco Products/Tobacco User feesLung health issues (e.g.. asthma, TB & COPD)
S. 2057: A bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practitioners, and clinical
nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs
H.R. 1639/S. 1461: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2011
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2011
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Jan. 12, 2012.
Original Filing: 300436220.xml
Lobbying Issues
FY12 State/For. Ops.
FY12 Defense
FY12 Int/Env.
FY12 L-HHSFY12 MilCon/VA
FY12 Ag/FDA
FY12 Interior
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
HR 2112: Lung Cancer Mortality Reduction Act
HR 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic
obstructive pulmonary disease
Center for Tobacco Products/Tobacco User feesLung health issues (eg. asthma, TB & COPD)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2011
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Oct. 13, 2011.
Original Filing: 300413117.xml
Lobbying Issues
FY12 State/For. Ops.
FY12 Defense
HR 1475- CR
FY12 L-HHSFY12 CR
FY12 MilCon/VA
FY12 Ag/FDA
FY12 Interior
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
HR 2112: Lung Cancer Mortality Reduction Act
HR 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic
obstructive pulmonary disease
Center for Tobacco Products/Tobacco User feesHR 2954: Health Equity Accountability Act
Lung health issues (eg. asthma, TB & COPD)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2011
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on July 13, 2011.
Original Filing: 300388896.xml
Lobbying Issues
FY12 State/For. Ops.
FY12 Defense
HR 1475- CR
FY12 L-HHSFY12 Interior
FY12 MilCon/VA
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
HR 2112: Lung Cancer Mortality Reduction Act
HR 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic
obstructive pulmonary disease
Center for Tobacco Products/Tobacco User feesLung health issues (eg, asthma, TB & COPD)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2011
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on April 14, 2011.
Original Filing: 300364154.xml
Lobbying Issues
FY11 Labor-HHS Appropriations Bill
FY11 VA Bill
FY12 L-HHS
FY12 Interior
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 2112: Lung Cancer Mortality Reduction Act
HR 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic obstructive pulmonary disease
Center for Tobacco Products/Tobacco User fees
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA)
4th Quarter, 2010
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Jan. 20, 2011.
Original Filing: 300350355.xml
Lobbying Issues
FY11 Labor -HHS Appropriations Bill
FY11 Interior Bill
FY11 VA Bill
FY11 Foreign Operations BillFY11 DoD
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 2112: Lung Cancer Mortality Reduction Act
HR 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic obstructive pulmonary disease
Center for Tobacco Products/Tobacco User fees
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA)
3rd Quarter, 2010
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Oct. 8, 2010.
Original Filing: 300309935.xml
Lobbying Issues
FY11 Labor -HHS Appropriations Bill
FY11 Interior Bill
FY11 VA Bill
FY11 Foreign Operations BillFY11 DoD
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 2112: Lung Cancer Mortality Reduction Act
HR 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic obstructive pulmonary disease
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2010
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on July 13, 2010.
Original Filing: 300284624.xml
Lobbying Issues
FY11 Labor -HHS Appropriations Bill
FY11 Interior Bill
FY11 VA Bill
FY11 Foreign Operations BillFY11 Defense Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 2112: Lung Cancer Mortality Reduction Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2010
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on April 15, 2010.
Original Filing: 300259065.xml
Lobbying Issues
FY11 Labor-HHS Appropriations Bill
FY11 Interior Bill
FY11 VA Bill
FY11 Foreign Operations BillFY11 Defense Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 3590: The Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2009
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Jan. 7, 2010.
Original Filing: 300227885.xml
Lobbying Issues
FY10 Labor-HHS Bill
FY10 Interior Bill
FY10 VA Bill
FY10 Foreign Operations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 3590: The Patient Protection and Affordable Care Act
HR 3962: Affordable Health Care for American Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2009
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on Oct. 2, 2009.
Original Filing: 300200260.xml
Lobbying Issues
FY10 Labor-HHS Bill
FY10 Interior Bill
FY10 VA Bill
FY10 Foreign Operations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1256 & S 982: Family Smoking Prevention & Tobacco Control-All Sections
HR 1: American Recovery & Reinvestment Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2009
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on July 7, 2009.
Original Filing: 300173126.xml
Lobbying Issues
FY10 Labor-HHS Bill
FY10 Interior Bill
FY10 VA Bill
FY10 Foreign Operations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1256 & S 982: Family Smoking Prevention & Tobacco Control-All Sections
HR 1: American Recovery & Reinvestment Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2009
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION , earning $10,000. The report was filed on April 20, 2009.
Original Filing: 300157223.xml
Lobbying Issues
FY 10 Labor-HHS Bill
FY 10 Interior Bill
FY 10 VA Bill
FY 10 Foreign Operations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1256: Family Smoking Prevention & Tobacco Control - All Sections
HR 1: American Recovery & Reinvestment Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2008
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION . The report was filed on Jan. 16, 2009.
Original Filing: 300121967.xml
Lobbying Issues
FY 09 Labor-HHS Bill
FY 09 Interior Bill
FY 09 VA Bill
FY 09 Foreign Operations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR. 1567/ S. 968: Stop Tuberculosis Now Act of 2007- All Sections
HR. 1532/ S. 1551: Comprehensive Tuberculosis Act of 2007- All Sections
HR. 1108/ S. 625: Family Smoking Prevention & Tobacco Control- All Sections
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2008
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION . The report was filed on Oct. 20, 2008.
Original Filing: 300102879.xml
Lobbying Issues
FY 09 Labor-HHS Bill
FY 09 Interior Bill
FY 09 VA Bill
FY 09 Foreign Operations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR. 1567/ S. 968: Stop Tuberculosis Now Act of 2007- All Sections
HR. 1532/ S. 1551: Comprehensive Tuberculosis Act of 2007- All Sections
GR. 1108/ S. 625: Family Smoking Prevention & Tobacco Control- All Sections
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2008
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION . The report was filed on July 21, 2008.
Original Filing: 300076970.xml
Lobbying Issues
FY 09 Labor-HHS Bill
FY 09 Interior Bill
FY 09 VA Bill
FY 09 Foreign Operations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1567/ S 968: Stop Tuberculosis Now Act of 2007- All Sections
HR 1532/ S 1551: Comprehensive Tuberculosis Act of 2007- All Sections
HR 5501/ S 2731: Tom Lantos & Henry J Hyde Global Leadership Against HIV/AIDS, Tuberculosis & Malaria Reauth. Sec. 302
HR 1108/ S 625: Family Smoking Prevention & Tobacco Control Act-All Sections
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2008
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN LUNG ASSOCIATION . The report was filed on April 18, 2008.
Original Filing: 300044116.xml
Lobbying Issues
FY 09 Labor-HHS Bill
FY 09 Interior Bill
FY 09 VA Bill
FY 09 Foreign Operations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1567/S. 968: Stop Tuberculosis Now Act of 2007-All Sections
HR 1532/S. 1551: Comprehensive Tuberculosis Act of 2007-All Sections
HR 5501/S. 2731:Tom Lantos & Henry J Hyde Global Leadership Against HIV/AIDS, Tuberculosis & Malaria Reauth. Sec. 302
HR 1108/S. 625: Family Smoking Prevention & Tobacco Control Act-All Sections
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate